RT Journal Article
SR Electronic
T1 Studies of Novel Coronavirus Disease 19 (COVID-19) Pandemic: A Global Analysis of Literature
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20092635
DO 10.1101/2020.05.05.20092635
A1 Tran, Bach Xuan
A1 Ha, Giang Hai
A1 Nguyen, Long Hoang
A1 Vu, Giang Thu
A1 Phan, Hai Thanh
A1 Le, Huong Thi
A1 Latkin, Carl A.
A1 Ho, Cyrus S.H.
A1 Ho, Roger C.M.
YR 2020
UL http://medrxiv.org/content/early/2020/05/08/2020.05.05.20092635.abstract
AB An exponential growth of literature about novel coronavirus disease 19 (COVID-19) has been observed in the last few months. This textual analysis of 5,780 publications extracted from the Web of Science, Medline, and Scopus databases was performed to explore the current research focuses and propose further research agenda. The Latent Dirichlet allocation was used for topic modeling. Regression analysis was conducted to examine country variations in the research focuses. Results indicated that publications were mainly contributed by the United States, China, and European countries. Guidelines for emergency care and surgical, viral pathogenesis, and global responses in the COVID-19 pandemic were the most common topics. There was variation in the research approaches to mitigate COVID-19 problems in countries with different income and transmission levels. Findings highlighted the need for global research collaboration among high- and low/middle-income countries in the different stages of prevention and control the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch is supported by Vingroup Innovation Foundation (VINIF) in project code VINIF.2020.COVID-19.DA03Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from corresponding author upon reasonable request